HSPB6 and neoplasm: Despite the established tumor-suppressing properties of HSPB6 in BLCA, as evidenced through both in vivo and in vitro studies, bioinformatics analyses have revealed a paradox: HSPB6 expression is notably higher in normal tissues compared to its reduced levels in cancerous counterparts.